期刊
BLOOD COAGULATION & FIBRINOLYSIS
卷 33, 期 1, 页码 25-33出版社
LIPPINCOTT WILLIAMS & WILKINS
DOI: 10.1097/MBC.0000000000001090
关键词
coagulation; fibrin structure; fibrinolysis; orthopaedic surgery; remote ischemic preconditioning
类别
资金
- University of Copenhagen
- Axel Muusfeldts Fond
- Snedkermester Sophus Jacobsen og Hustru Anna Jacobsens Fond
- Oda og Hans Svenningsens Fond
- Frimodt-Heineke Fonden
- Toyota Fonden
- Beckett Fonden
This study investigated the antithrombotic mechanisms of remote ischemic preconditioning (RIPC) in patients undergoing hip fracture surgery. The results showed that RIPC did not affect thrombin generation, fibrinogen/fibrin turnover, or fibrin structure in these patients.
Remote ischemic preconditioning (RIPC) prior to surgery has recently been shown to reduce the risk of myocardial injury and myocardial infarction after hip fracture surgery. This study investigated whether RIPC initiated antithrombotic mechanisms in patients undergoing hip fracture surgery. This trial was a predefined sub-study of a multicentre randomized clinical trial. Adult patients with cardiovascular risk factors undergoing hip fracture surgery between September 2015 and September 2017 were randomized 1 : 1 to RIPC or control. RIPC was initiated before surgery with a tourniquet applied to the upper arm and it consisted of four cycles of 5min of forearm ischemia followed by five minutes of reperfusion. The outcomes such as surgery-induced changes in thrombin generation, fibrinogen/fibrin turnover, tissue plasminogen activator, plasminogen activator inhibitor-1 and fibrin structure measurements were determined preoperatively (prior to RIPC) and 2 h postoperatively. One hundred and thirty-seven patients were randomized to RIPC (nU65) or control (nU72). There were no significant changes in thrombin generation, fibrinogen/fibrin turnover or fibrin structure measurements determined pre and postoperatively between patients in the RIPC and control groups. Subgroup analyses on patients not on anticoagulant therapy (nU103), patients receiving warfarin (nU17) and patients receiving direct oral anticoagulant therapy (nU18) showed no significant changes between the RIPC-patients and controls. RIPC did not affect changes in thrombin generation, fibrin turnover or fibrin structure in adult patients undergoing hip fracture surgery suggesting that the cardiovascular effect of RIPC in hip fracture surgery is not related to alterations in fibrinogen/fibrin metabolism. Blood Coagul Fibrinolysis 33:25- 33 Copyright (c) 2021 The Author(s). Published by Wolters Kluwer Health, Inc.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据